Virus News and Research

Latest Virus News and Research

Dozens of U.S. hospitals poised to defy FDA’s directive on COVID plasma

Dozens of major hospitals across the U.S. are grappling with whether to ignore a federal decision allowing broader emergency use of blood plasma from recovered COVID patients to treat the disease in favor of dedicating their resources to a gold-standard clinical trial that could help settle the science for good.

3 Sep 2020

Improving COVID-19 diagnosis

News-Medical spoke to Yourgene health on their efforts during the COVID-19 pandemic, and how they developed a diagnostic test for COVID-19.

From Yourgene Health 3 Sep 2020

New grant supports research into diabetic kidney disease and COVID-19

Mater and University of Queensland Researcher Dr Mitchell Sullivan has been awarded a 2020 Advance Queensland Industry Research Fellowship from the Queensland Government to fund his research into diabetic kidney disease and COVID-19.

3 Sep 2020

Increased COVID-19 cases in India raise questions about reopening the economy

A spike in COVID-19 infections in India, reaching an average of more than 70,000 cases per day over the past week, has raised questions about reopening the economy, which contracted by 24 per cent of GDP as a result of a drastic national lockdown imposed in March to stop the virus from spreading.

3 Sep 2020

Corticosteroids can be lifesaving for critically ill COVID-19 patients

Now, a prospective meta-analysis of 7 randomized trials published in the journal JAMA showed that the widely available steroid drugs could help seriously ill patients survive COVID-19.

3 Sep 2020

COVID-19 virus and antibodies can coexist in young patients, shows study

With many questions remaining around how children spread COVID-19, Children's National Hospital researchers set out to improve the understanding of how long it takes pediatric patients with the virus to clear it from their systems, and at what point they start to make antibodies that work against the coronavirus.

3 Sep 2020

Reformulated generic drug could offer a cost-effective way to accelerate recovery, prevent hospitalizations

Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations.

3 Sep 2020

AAV gene therapy often leads to dorsal root ganglion pathology, show studies

A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.

3 Sep 2020

New Gyrolab AAVX Titer Kit launched to support the development cell and gene therapies

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® AAVX Titer Kit for adeno-associated virus (AAV) vector titer determination in AAV vector manufacturing.

From Gyros Protein Technologies AB 3 Sep 2020

Bioengineering technique that boosts protein production could lead to effective COVID-19 vaccine

A bioengineering technique to boost production of specific proteins could be the basis of an effective vaccine against the novel coronavirus that causes COVID-19, new research suggests.

3 Sep 2020

Researchers identify properties in placenta tissue that may prevent COVID-19 transmission

Researchers from Boston Medical Center's Maxwell Finland Laboratory for Infectious Diseases have identified properties in placenta tissue that may play an important role in preventing the transmission of COVID-19 from a mother with the virus to her fetus.

3 Sep 2020

Study shows why coronavirus is more dangerous in people with comorbidities

Why is the COVID-19 virus more dangerous in people with comorbidities?. Sadis Matalon, Ph.D., of the University of Alabama at Birmingham and colleagues in Texas and San Francisco asked that question in a hypothesis paper published online in Physiological Reviews on March 27.

3 Sep 2020

Antibody responses in recovered COVID-19 individuals from India

India has been hit hard by COVID-19, with at least 66,000 deaths and almost 4 million cases. The need to understand the infection, including the various antibody isotypes, and whether neutralizing antibodies and memory B cells are being produced, has driven much research into the way immunity is developing in Indian patients.

3 Sep 2020

VUMC launches clinical trial of promising COVID-19 treatments in outpatient setting

Vanderbilt University Medical Center is launching a clinical trial of promising treatments for COVID-19 in the outpatient setting.

2 Sep 2020

UC San Diego participates in second, massive clinical trial of COVID-19 vaccine

UC San Diego Health will be part of a second, massive clinical trial to assess the safety, efficacy and immunogenicity of a vaccine designed to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.

2 Sep 2020

Combined point-of-care nucleic acid and antibody testing increases COVID-19 detection

A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease.

2 Sep 2020

Honeybee venom induces cancer cell death in aggressive breast cancer

The new study, published in the journal Nature Precision Oncology, highlights how bees can help combat breast cancer. The research team found that when the venom’s main component, when mixed with existing chemotherapy drugs, reduced tumor growth in laboratory mice.

2 Sep 2020

Study shows SARS-CoV-2 jumps back and forth between animals and humans on mink farms

An in-depth investigation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks on 16 mink farms by researchers from the Netherlands revealed that minks might serve as a reservoir for persistent infection in humans. The study is currently available on bioRxiv* preprint server.

2 Sep 2020

Treating critically ill COVID-19 patients with steroid improves chances of recovery

A new international study published today [02 September] has shown that treating critically ill patients with COVID-19 with the steroid hydrocortisone improves their chances of recovery.

2 Sep 2020

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).

2 Sep 2020

Virus News and Research

Latest Virus News and Research

Dozens of U.S. hospitals poised to defy FDA’s directive on COVID plasma

Improving COVID-19 diagnosis

New grant supports research into diabetic kidney disease and COVID-19

Increased COVID-19 cases in India raise questions about reopening the economy

Corticosteroids can be lifesaving for critically ill COVID-19 patients

COVID-19 virus and antibodies can coexist in young patients, shows study

Reformulated generic drug could offer a cost-effective way to accelerate recovery, prevent hospitalizations

AAV gene therapy often leads to dorsal root ganglion pathology, show studies

New Gyrolab AAVX Titer Kit launched to support the development cell and gene therapies

Bioengineering technique that boosts protein production could lead to effective COVID-19 vaccine

Researchers identify properties in placenta tissue that may prevent COVID-19 transmission

Study shows why coronavirus is more dangerous in people with comorbidities

Antibody responses in recovered COVID-19 individuals from India

VUMC launches clinical trial of promising COVID-19 treatments in outpatient setting

UC San Diego participates in second, massive clinical trial of COVID-19 vaccine

Combined point-of-care nucleic acid and antibody testing increases COVID-19 detection

Honeybee venom induces cancer cell death in aggressive breast cancer

Study shows SARS-CoV-2 jumps back and forth between animals and humans on mink farms

Treating critically ill COVID-19 patients with steroid improves chances of recovery

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Virus News and Research

Latest Virus News and Research

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Newsletters you may be interested in